Published From September 21st – 23rd, 2023, Assoc. Prof. Siwanon Jirawatnotai, representing the Department of Pharmacology at the Faculty of Medicine, Siriraj Hospital, Mahidol University, made a significant contribution at the 82nd Annual Meeting of the Japanese Cancer Association (JCA). He shared his valuable insights on the topic, ‘’Acquired Vulnerability Screening Unveiled Novel Candidate Drug Targets in the Drug Resistant Cholangiocarcinoma.”
The JCA is a distinguished organization of 13,000 researchers engaged in cancer research and studies related to public health and social medicine, providing a platform for collaboration among professionals with diverse specializations.
This engagement by Assoc. Prof. Siwanon Jirawatnotai and the broader efforts of the Japanese Cancer Association exemplify a commitment to advancing cancer research and its global reach, ultimately working towards better outcomes for patients worldwide.
